China Health Group Inc. Announces Trading Suspension on Hong Kong Exchange Pending Subsidiary Sale Announcement
Reuters
Sep 03
China Health Group Inc. Announces Trading Suspension on Hong Kong Exchange Pending Subsidiary Sale Announcement
China HealthCare Holdings Limited, listed under the ticker 673, announced a trading suspension of its shares on February 1, 2008, at 9:30 AM. The halt was requested by the company pending the release of an announcement related to the sale of a subsidiary, which involves price-sensitive information. The company's board of directors includes Dr. Lee Chong Yuen, Mr. Lee Jong Dae, and Mr. Chau Po Yee as executive directors, Mr. Martin Treffer as a non-executive director, and Mr. Mu Xiang Ming, Mr. Jiang Bo, and Dr. Yan Shiyun as independent non-executive directors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Health Group Inc. published the original content used to generate this news brief on September 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.